BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21980038)

  • 1. Aberrant expression of chromogranin A, miR-146a, and miR-146b-5p in prostate structures with focally disrupted basal cell layers: an early sign of invasion and hormone-refractory cancer?
    Man YG; Fu SW; Liu AJ; Stojadinovic A; Izadjoo MJ; Chen L; Gardner WA
    Cancer Genomics Proteomics; 2011; 8(5):235-44. PubMed ID: 21980038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
    Man YG; Gardner WA
    Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell clusters overlying focally disrupted mammary myoepithelial cell layers and adjacent cells within the same duct display different immunohistochemical and genetic features: implications for tumor progression and invasion.
    Man YG; Tai L; Barner R; Vang R; Saenger JS; Shekitka KM; Bratthauer GL; Wheeler DT; Liang CY; Vinh TN; Strauss BL
    Breast Cancer Res; 2003; 5(6):R231-41. PubMed ID: 14580259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential impact of tumor-infiltrating immune cells on basal and luminal cells: implications for tumor invasion and metastasis.
    Song G; Hsiao H; Wang JL; Mannion C; Stojadinovic A; Avital I; Fu SW; Mason J; Chen W; Jewett A; Li H; Man YG
    Anticancer Res; 2014 Nov; 34(11):6363-80. PubMed ID: 25368236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic role of immunohistochemical chromogranin a expression in prostate cancer patients is significantly modified by androgen-deprivation therapy.
    Berruti A; Bollito E; Cracco CM; Volante M; Ciccone G; Porpiglia F; Papotti M; Scarpa RM; Dogliotti L
    Prostate; 2010 May; 70(7):718-26. PubMed ID: 20087896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal prostate basal cell layer disruptions and leukocyte infiltration are correlated events: A potential mechanism for basal cell layer disruptions and tumor invasion.
    Man YG; Shen T; Zhao Y; Amy Sang QX
    Cancer Detect Prev; 2005; 29(2):161-9. PubMed ID: 15829376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA profiles of healthy basal and luminal mammary epithelial cells are distinct and reflected in different breast cancer subtypes.
    Bockmeyer CL; Christgen M; Müller M; Fischer S; Ahrens P; Länger F; Kreipe H; Lehmann U
    Breast Cancer Res Treat; 2011 Dec; 130(3):735-45. PubMed ID: 21409395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical study of chromogranin A in Stage D2 prostate cancer.
    Kokubo H; Yamada Y; Nishio Y; Fukatsu H; Honda N; Nakagawa A; Saga S; Tsuzuki T; Hara K
    Urology; 2005 Jul; 66(1):135-40. PubMed ID: 15992907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasma chromogranin-A (CgA)--a potential marker for diagnosis, monitoring and management of prostate cancer patients].
    Leibovitch I; Pinthus Y; Sella BA; Ramon J
    Harefuah; 2006 Jan; 145(1):25-9, 78. PubMed ID: 16450720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease.
    Berruti A; Mosca A; Tucci M; Terrone C; Torta M; Tarabuzzi R; Russo L; Cracco C; Bollito E; Scarpa RM; Angeli A; Dogliotti L
    Endocr Relat Cancer; 2005 Mar; 12(1):109-17. PubMed ID: 15788643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A subset of in situ breast tumor cell clusters lacks expression of proliferation and progression related markers but shows signs of stromal and vascular invasion.
    Man YG; Shen T; Weisz J; Berg PE; Schwartz AM; Mulshine JL; Sang QX; Nieburgs HE
    Cancer Detect Prev; 2005; 29(4):323-31. PubMed ID: 16122886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-146b acts as a potential tumor suppressor in human prostate cancer.
    Ding HY; Qian WQ; Xu J
    J BUON; 2016; 21(2):434-43. PubMed ID: 27273955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlated alterations in prostate basal cell layer and basement membrane.
    Liu A; Wei L; Gardner WA; Deng CX; Man YG
    Int J Biol Sci; 2009; 5(3):276-85. PubMed ID: 19343113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical E-cadherin expression in cell clusters overlying focally disrupted mammary myoepithelial cell layers: implications for tumor cell motility and invasion.
    Zhang X; Hashemi SS; Yousefi M; Gao C; Sheng J; Ni J; Wang W; Mason J; Man YG
    Pathol Res Pract; 2009; 205(6):375-85. PubMed ID: 19395181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of miR-146a in gastric cancer cases.
    Kogo R; Mimori K; Tanaka F; Komune S; Mori M
    Clin Cancer Res; 2011 Jul; 17(13):4277-84. PubMed ID: 21632853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon.
    Gandellini P; Folini M; Longoni N; Pennati M; Binda M; Colecchia M; Salvioni R; Supino R; Moretti R; Limonta P; Valdagni R; Daidone MG; Zaffaroni N
    Cancer Res; 2009 Mar; 69(6):2287-95. PubMed ID: 19244118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine expression in metastatic prostate cancer: evaluation of high throughput tissue microarrays to detect heterogeneous protein expression.
    Mucci NR; Akdas G; Manely S; Rubin MA
    Hum Pathol; 2000 Apr; 31(4):406-14. PubMed ID: 10821485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of basal cell keratins in human prostate cancer metastases and cell lines.
    van Leenders GJ; Aalders TW; Hulsbergen-van de Kaa CA; Ruiter DJ; Schalken JA
    J Pathol; 2001 Dec; 195(5):563-70. PubMed ID: 11745692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NeuroD1 expression in human prostate cancer: can it contribute to neuroendocrine differentiation comprehension?
    Cindolo L; Franco R; Cantile M; Schiavo G; Liguori G; Chiodini P; Salzano L; Autorino R; Di Blasi A; Falsaperla M; Feudale E; Botti G; Gallo A; Cillo C
    Eur Urol; 2007 Nov; 52(5):1365-73. PubMed ID: 17126478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells.
    Li T; Li D; Sha J; Sun P; Huang Y
    Biochem Biophys Res Commun; 2009 Jun; 383(3):280-5. PubMed ID: 19302977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.